Amiodarone use in therapeutic hypothermia following cardiac arrest due to ventricular tachycardia and ventricular fibrillation

Europace

Volumn 11, Issue 11, 2009, Pages 1566-1567

  Khan, Jamal Nasir ^a   Prasad, Neeraj ^a   Glancy, James ^a  

^a WYE VALLEY NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ARRHYTHMOGENESIS; CLINICAL ARTICLE; CLINICAL PRACTICE; DRUG MONITORING; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INDUCED HYPOTHERMIA; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT PROLONGATION; RESUSCITATION; TORSADE DES POINTES;

ADULT; BODY TEMPERATURE; CRYOTHERAPY; ELECTROCARDIOGRAPHY; HUMANS; HYPOTHERMIA, INDUCED; MALE; MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 71049161532     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup233     Document Type: Letter

References (5)

1. Richter S, Ehrlich JR, Fabbender S, Fichtlscherer S. Malignant Osborn waves during therapeutic hypothermia. Europace 2009;11:668-669
2. Milanovic R, Husedzinovic S, Bradic N. Induced hypothermia after cardiopulmonary resuscitation: Possible adverse effects. Signa Vitae 2007;2: 15-17.
3. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003;89: 1363-1372
4. Dapro B. Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes. Eur Heart J 2001;3(Suppl. K):K70-80.
5. Nolan JP, Deakin CD, Soar J, Battiger BW, Smith G et al. European resuscitation council guidelines for resuscitation. Resuscitation 2005;67(Suppl. 1): 21-189.